Category Archives: Meetings

The Sunshine Act: Cloudier Still?

By Clark Herman | Published: February 7, 2013
With the recent release of the Patient Protection Sunshine Act (PPSA), the Center for Medicare and Medicaid Services (CMS) has established reporting requirements to ensure that drug manufacturers properly disclose payments to physicians in areas of research, continuing medical education, etc. However a key uncertainty is the issue of state pre-emption. While state and local [...]
Also posted in Legal, Manufacturing, Medical Education, Regulatory, compliance | Tagged , , | 1 Comment

Pharma's Promotional Spend: What's the Right Target?

By Clark Herman | Published: January 17, 2013
Global consultancy Cegedim has released its latest survey on how and where big Pharma puts its promotional dollar. Pharmaceutical Promotional Spend: Global Trends reports that spending in emerging markets significantly increased last year, while Europe and US declined slightly.  Although overall promotion spending remained flat worldwide at $90 billion, the US still accounts for the [...]
Also posted in Advertising, Emerging Markets, Europe, Global, Marketing, Sales, Strategy, Technology, social media | Tagged , , , , , | Leave a comment

Pharma in the Dell: Working with Academia

By Ben Comer | Published: November 14, 2012
How can the emerging field of data science help to fruitfully translate research and discovery into successful drug development? Academics and pharmaceutical executives at Mount Sinai’s School of Medicine discussed ways to build a bridge across the valley of death, and the growing importance of data across all business areas.
Also posted in Biotech, Deals, IP, People, R&D, Strategy, Technology, leadership | Tagged , , , , , , | Leave a comment

Diabetes Drug Launch 2012: Tip-tops and Promo-flops

By Clark Herman | Published: October 12, 2012
With Halloween candy flooding the shelves in pharmacies across the nation, it’s only appropriate that we turn the conversation toward an ever-growing drug market and therapeutic area: diabetes.
Also posted in Advertising, E-Media, FDA, Marketing, Strategy | Tagged , , , , , | 1 Comment

FDA, AdvaMed Seeking Clarity on Med Device Pre-Market Approvals

By Guest Blogger | Published: September 5, 2012
by Elizabeth Hollis The FDA and the Advanced Medical Technology Association (AdvaMed) gave cardiovascular device manufacturers plenty to think about over the holiday weekend with information presented at an Aug. 28 workshop. The two bodies came together to explain requirements for 30-day notices and annual change reports for Pre-Market Approvals (PMAs), an important gateway to [...]
Also posted in FDA, Guest Blog, IP, Legal, Manufacturing, Market Access, Regulatory, Safety, Strategy, Technology | Tagged , | 1 Comment